| Product Code: ETC7652716 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Granuloma Inguinale Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Granuloma Inguinale Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Granuloma Inguinale Market - Industry Life Cycle |
3.4 Israel Granuloma Inguinale Market - Porter's Five Forces |
3.5 Israel Granuloma Inguinale Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Israel Granuloma Inguinale Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Granuloma Inguinale Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about sexually transmitted infections (STIs) leading to early diagnosis and treatment of granuloma inguinale |
4.2.2 Advancements in medical research and technology improving diagnostic accuracy and treatment options |
4.2.3 Rising prevalence of granuloma inguinale among the population in Israel |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare facilities for the diagnosis and treatment of granuloma inguinale |
4.3.2 Lack of comprehensive public health programs addressing STI prevention and control in Israel |
5 Israel Granuloma Inguinale Market Trends |
6 Israel Granuloma Inguinale Market, By Types |
6.1 Israel Granuloma Inguinale Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Israel Granuloma Inguinale Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Israel Granuloma Inguinale Market Revenues & Volume, By Azithromycin, 2021- 2031F |
6.1.4 Israel Granuloma Inguinale Market Revenues & Volume, By Doxycycline, 2021- 2031F |
6.1.5 Israel Granuloma Inguinale Market Revenues & Volume, By Ciprofloxacin, 2021- 2031F |
6.1.6 Israel Granuloma Inguinale Market Revenues & Volume, By Erythromycin, 2021- 2031F |
6.2 Israel Granuloma Inguinale Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Israel Granuloma Inguinale Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.3 Israel Granuloma Inguinale Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.2.4 Israel Granuloma Inguinale Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2.5 Israel Granuloma Inguinale Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Granuloma Inguinale Market Import-Export Trade Statistics |
7.1 Israel Granuloma Inguinale Market Export to Major Countries |
7.2 Israel Granuloma Inguinale Market Imports from Major Countries |
8 Israel Granuloma Inguinale Market Key Performance Indicators |
8.1 Number of reported cases of granuloma inguinale in Israel |
8.2 Percentage of the population undergoing regular STI screenings |
8.3 Funding allocated for research and development of treatments for granuloma inguinale |
9 Israel Granuloma Inguinale Market - Opportunity Assessment |
9.1 Israel Granuloma Inguinale Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Israel Granuloma Inguinale Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Granuloma Inguinale Market - Competitive Landscape |
10.1 Israel Granuloma Inguinale Market Revenue Share, By Companies, 2024 |
10.2 Israel Granuloma Inguinale Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here